EU
OMass Therapeutics
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics for rare diseases and immunological conditions using its OdyssION platform.
omass.com
1
aktive Jobs
Alle Jobs des Unternehmens ansehen
Hybrid 1
Über das Unternehmen
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics. Its work focuses on rare diseases and immunological conditions, with programmes aimed at targets such as membrane proteins, intracellular complexes, solute carriers and GPCRs. The company describes its OdyssION platform as combining novel biochemistry, native mass spectrometry and custom chemistry.
Hinweise für Kandidaten
- Biotechnology company developing small-molecule therapeutics.
- Focuses on rare diseases and immunological conditions.
- Uses the OdyssION technology platform for drug discovery.
- Wirtschaftssektor
- Biotechnology
- Kommerzieller Fokus
- Drug discovery and development of small-molecule therapeutics
- Hauptsitz
- Oxford
Aktuelle Stellen
1
aktive Jobs
- Wichtigste Städte
- Oxford (1)
- Arbeitsort
- Hybrid (1)
- Anstellung
- Vollzeit (1)